Drug-Resistant Tuberculosis:

Efforts to curb drug-resistant TB must focus on faster diagnostics and effective second-line therapies. Global surveillance and containment strategies are paramount to stopping its spread. Addressing MDR-TB and XDR-TB requires substantial investment in patient-centered approaches and innovative drug formulations.

    Drug-Resistant Tuberculosis: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in